Clinical Aspects, Pathogenesis, and Therapy Options of Alopecia Induced by Hormonal Therapy for Breast Cancer
October 2021
in “
Exploration of targeted anti-tumor therapy
”
hormone-receptor-positive breast cancer oncotherapy-induced alopecia female androgenic alopecia estrogenic activity dehydrotestosterone DHT hair follicles hair growth phase topical hormones oncogenic effects topical formulations minoxidil 2% cetirizine 0.5% hydrocortisone butyrate minoxidil 5% hydrocortisone butyrate 0.1% breast cancer hormonal therapy hair loss female pattern baldness estrogen hair growth topical treatments cancer-causing effects topical solutions Rogaine cetirizine hydrocortisone
Studysummary This review describes oncotherapy-induced alopecia in patients receiving hormone therapy for hormone-receptor-positive breast cancer and concludes that topical hormones should not be used due to oncogenic potential.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on explorationpub.com →